Indeed, the IgL locus has previously been identified as one of the strongest super-enhancers in the myeloma cell line MM.1S as indicated by the levels of histone 3 lysine 27 acetylation (H3K27ac), or MED1 and BRD4 occupancy29. Here, MED1 is linked to plasma cell myeloma.